Partnership with TetraGenetics targets Type 1 diabetes

New partnership hopes to accelerate the development of a cure for Type 1 Diabetes.

LifeArc appointments strengthen board of trustees

LifeArc has strengthened its board by appointing three new trustees.

Collaboration: Just the latest buzzword in medical research?

(Blog first appeared on AMRC website on 4 December 2017. )   Mike Johnson, Executive Director, Business Development,…

Tumour analysis following surgery could provide breakthrough in predicting how well cancer patients respond to drug treatment

A new platform for assessing anti-cancer drug efficacy could expedite the discovery of new cancer therapies.

Timur Avkiran awarded Industrial Fellowship

The Royal Commission for the Exhibition of 1851 has awarded Industrial Fellowships worth up to £80,000 to…

SpringWorks Therapeutics launched to progress investigational therapies for patients with unmet medical needs

Four therapies could lead to new treatments for desmoid tumours, neurofibromatosis, hereditary xerocystosis and post-traumatic stress disorder.

LifeArc and AUTM forge international partnership to provide training for scholars in technology transfer

We have partnered with The Association of University Technology Managers (AUTM) Foundation to offer a competitive program that will provide essential training for scientists seeking a career in life sciences technology transfer.

LifeArc splashes out, fuelled by Keytruda

Article in Nature Biotechnology about our new name and plans for the future (subscription needed to read…

LifeArc launches £100,000 awards – now closed

We have launched the LifeArc Translational Award for academic scientists to progress early stage drug discovery projects.